Lippo Karawaci Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Lippo Karawaci Tbk. trades at Rp61 (market cap 4.32T, 78.75M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp236 (market cap 428.75B, 13.83M 24h volume). The key difference: Lippo Karawaci Tbk. is far larger — about 10.1× Prodia Diagnostic Line Tbk's market cap, and Lippo Karawaci Tbk. is more actively traded (78.75M versus 13.83M). Which is the better fit depends on your goals.
| LPKR | PRDL | |
|---|---|---|
Market Cap | 4.32T | 428.75B |
Volume | 78.75M | 13.83M |
Lot | 787.51K | 138.27K |
Turnover | 4.81B | 3.27B |
Average Price | 61.05 | 236.62 |
Value | 4.81B | 3.27B |
Indicative Equilibrium Price | 61 | 236 |
Indicative Equilibrium Volume | 28.62K | 1.74K |
Trailing returns across standard periods
Latest headlines on both assets
PT Lippo Karawaci Tbk was established under the name of PT Tunggal Reksakencana on October, 1990. The Company's scope of activities includes real estate, urban development and infrastructure, industrial estate development, general facilities and infrastructure development, services and investments, both direct and indirect, either through its subsidiaries or in joint venture with other parties.
Read more on LPKR →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →